Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23153 | 301 | 43.9 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3349 | 1249 | CARRIER ERYTHROCYTES//VASCULAR IMMUNOTARGETING//NANOERYTHROSOMES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CAROLINA CANC NANOTECHNOL EXCELLENCE | Address | 12 | 41% | 7% | 22 |
2 | ARTIFICIAL ANTIGEN PRESENTING CELL | Author keyword | 9 | 64% | 3% | 9 |
3 | SLOAN KETTERING CANC | Address | 6 | 23% | 8% | 23 |
4 | PARACRINE DELIVERY | Author keyword | 3 | 60% | 1% | 3 |
5 | ANTIGEN SPECIFIC CD8T CELLS | Author keyword | 1 | 100% | 1% | 2 |
6 | CAUDILL S 257 | Address | 1 | 100% | 1% | 2 |
7 | DIFFUSIVE INTERACTIONS | Author keyword | 1 | 100% | 1% | 2 |
8 | HLA A2 IG | Author keyword | 1 | 100% | 1% | 2 |
9 | HLA IG DIMER | Author keyword | 1 | 100% | 1% | 2 |
10 | LARGE MULTIVALENT IMMUNOGEN VACCINE | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLASS I PEPTIDE COMPLEXES | 11 | 78% | 2% | 7 |
2 | LARGE MULTIVALENT IMMUNOGEN | 9 | 67% | 3% | 8 |
3 | PRINT NANOPARTICLES | 6 | 100% | 1% | 4 |
4 | PRINT PARTICLES | 6 | 100% | 1% | 4 |
5 | BIOADHESIVE MICRODEVICES | 3 | 100% | 1% | 3 |
6 | EXPRESSING FAS LIGAND | 2 | 50% | 1% | 3 |
7 | ENGINEERED DRUG THERAPIES | 2 | 43% | 1% | 3 |
8 | CTL ACTIVITY | 1 | 33% | 1% | 3 |
9 | MHC PROTEINS | 1 | 30% | 1% | 3 |
10 | CLASS I PROTEIN | 1 | 40% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications | 2015 | 2 | 97 | 25% |
Linking form to function: Biophysical aspects of artificial antigen presenting cell design | 2015 | 2 | 160 | 19% |
The importance of nanoparticle shape in cancer drug delivery | 2015 | 2 | 117 | 15% |
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics | 2011 | 73 | 57 | 30% |
Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells | 2014 | 4 | 86 | 41% |
Utilization of "Shuttle & Find" for Uptake Analysis of Substructured, Rodshaped Microparticles by Alveolar Macrophages | 2013 | 0 | 3 | 100% |
Future of the Particle Replication in Nonwetting Templates (PRINT) Technology | 2013 | 15 | 67 | 30% |
More Effective Nanomedicines through Particle Design | 2011 | 110 | 133 | 12% |
Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy | 2010 | 21 | 71 | 31% |
Biomimetic Delivery with Micro- and Nanoparticles | 2012 | 41 | 175 | 14% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CAROLINA CANC NANOTECHNOL EXCELLENCE | 12 | 41% | 7.3% | 22 |
2 | SLOAN KETTERING CANC | 6 | 23% | 7.6% | 23 |
3 | CAUDILL S 257 | 1 | 100% | 0.7% | 2 |
4 | MALONE ENGN | 1 | 20% | 1.7% | 5 |
5 | VET NUCL MED | 1 | 33% | 0.7% | 2 |
6 | CELL BIOL CELL BIOL | 1 | 50% | 0.3% | 1 |
7 | IMMUNOTHER EUT MED | 1 | 50% | 0.3% | 1 |
8 | SCI FDN EXPERIENCE UNDER | 1 | 50% | 0.3% | 1 |
9 | CANC WALES | 1 | 29% | 0.7% | 2 |
10 | OFF CANC NANOTECHNOL | 1 | 29% | 0.7% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000179324 | VASCULAR IMMUNOTARGETING//TARGETED THER EUT TRANSLAT NANOMED//TRANSLAT TARGETED THER EUT NANOMED |
2 | 0.0000157766 | PERSONALIZED DOSING//THREE DIMENSIONAL PRINTING TM//SULPHOALUMINATE MDF CEMENT |
3 | 0.0000143069 | JANUS PARTICLES//PATCHY PARTICLES//PATCHY COLLOIDS |
4 | 0.0000142790 | SOFT CONDENSED MATTER PHYS INTERDISCIPLINAR//PASSIVE ENDOCYTOSIS//SPIO NANOPARTICLE |
5 | 0.0000102098 | CHIMERIC LIPOSOMES//NONLINEAR COMPARTMENTAL MODEL//FRACTIONAL KINETICS |
6 | 0.0000098531 | POROUS SILICON//POROUS SILICON NANOPARTICLES//XINJIANG BIOL OURCES GENE ENGN |
7 | 0.0000095968 | CHIMERIC ANTIGEN RECEPTOR//ADOPTIVE CELL THERAPY//CHIMERIC IMMUNE RECEPTOR |
8 | 0.0000088125 | CMV SPECIFIC T CELLS//ONCOHEMATOL GRP//CYTOMEGALOVIRUS SPECIFIC T CELLS |
9 | 0.0000083531 | VACCINE DELIVERY//PLG MICROPARTICLES//ADJUVANT UNIT |
10 | 0.0000081986 | PEPTIDE MHC//PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX//PROT CRYSTALLOG UNIT |